Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
VREX · against 492 other Healthcare companies of similar size
Ranked #362 of 493 · scores higher than 27% of peers · safety percentile 30
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)40 peers with a safety percentile of 30–39, including VREX · Click a bar to see the companies
Mainly because of its debt / equity and beta, which are weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | VREX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 464 reported | 0.74× | 0.18× | 17% | 33% | |
| BetaLower is better · 469 reported | 0.96 | 0.41 | 23% | 33% | |
| Current ratioHigher is better · 486 reported | 3.38× | 2.83× | 57% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 1.5B USD | 100 | 44 | |
| 2 | 1.2B USD | 100 | 40 | |
| 3 | 1.1B USD | 100 | ||
| 4 | 1.0B USD | 99 | 35 | |
| 5 | 421M USD | 99 | 52 | |
| 358 | 470M EUR (≈$517M) | 31 | 56 | |
| 359 | 1.6B USD | 31 | 30 | |
| 360 | 1.2B USD | 31 | ||
| 361 | 3.5B CNY (≈$496M) | 31 | 18 | |
| 362 | 787M USD | 30 | 57 | |
| 363 | 433M USD | 30 | 81 | |
| 364 | 551M USD | 30 | 27 | |
| 365 | 110.9B JPY (≈$754M) | 30 | 59 | |
| 366 | 101.2B JPY (≈$688M) | 29 | 54 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score